You are here

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Thursday, September 6, 2018 - 11:30am
EDT

Pfizer Inc. invites investors and the general public to listen to a
webcast of a discussion with Frank D’Amelio, Executive Vice President,
Business Operations, and Chief Financial Officer, at the Morgan Stanley
16th Annual Global Healthcare Conference on Thursday,
September 13, 2018 at 2:55 p.m. Eastern Daylight Time.

To listen to the webcast, visit our web site at www.pfizer.com/investors.
Information on accessing and pre-registering for the webcast will be
available at www.pfizer.com/investors
beginning today.

Visitors will be able to listen to an archived copy of the webcast at www.pfizer.com/investors.


Disclosure Notice: The webcast may include forward-looking
statements about, among other things, our anticipated future operating
and financial performance, business plans and prospects, in-line
products and product candidates, strategic reviews, capital allocation,
plans to organize our commercial operations into three businesses
effective at the beginning of the company’s 2019 fiscal year,
business-development plans, the benefits expected from our business
development transactions and plans relating to share repurchases and
dividends that are subject to substantial risks and uncertainties that
could cause actual results to differ materially from those expressed or
implied by such statements. A description of these risks and
uncertainties can be found in Pfizer’s Annual Report on Form 10-K for
the fiscal year ended December 31, 2017 and in its subsequent reports on
Form 10-Q, including in the sections thereof captioned “Risk Factors”
and “Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of which
are filed with the U.S. Securities and Exchange Commission and available
at


www.sec.gov


and


www.pfizer.com

.

The forward-looking statements in the webcast speak only as of the
original date of the webcast. Pfizer assumes no obligation to update
forward-looking statements contained in the webcast as the result of new
information or future events or developments.



Contact: 

Pfizer Inc.
Media:
Joan Campion, 212-733-2798
or
Investors:
Ryan Crowe, 212-733-8160